Novartis and Sanofi-Genzyme have co-led a first funding round for NeuroVia, which will use the cash to advance development of a drug for a rare genetic neurological disease.

Medical device developer Amphora Medical has closed a $35.5m series B round co-led by Boston Scientific that will fund a pivotal study for its OAB treatment.

University of New Mexico has revealed it generated 12 new businesses during its financial year that ended June 30.

Bright.md, the provider of a virtual healthcare service backed by StartX, has raised $8m in its latest funding round.

Lightox, Horizon: Therapeutic Microbubbles and StrataStem are among the companies that will receive support from the North of England Life Sciences Accelerator.

Lundbeck's corporate venturing unit contributed to a series C round led by New Enterprise Associates which will advance Trevi Therapeutics' lead pruritus treatment.

GE Ventures has led a $14.1m series C round for online health insurance marketplace Gravie, a year after the company received $1m from insurer Securian.

Shandong Buchang Pharmaceuticals has taken part in a $17.7m round for Symbow Medical, which is working on a surgical navigation device.

Mayo Clinic, which co-launched artificial intelligence-equipped drug developer Qrative with AI software provider Nference, has also contributed to its $8.3m series A round.